Vito Racanelli
Overview
Explore the profile of Vito Racanelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
142
Citations
3503
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cai T, Brugnolli A, Lanzafame M, Dellai F, Tascini C, Scarparo C, et al.
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001454
: The management of urinary tract infections (UTIs) has become an increasingly challenging medical intervention. This study explores whether adoption of a precision medicine model could improve the management of...
2.
Osti N, Racanelli V, Susca N, Martinelli N, Maino A
Int J Cardiol Heart Vasc
. 2024 Dec;
56:101565.
PMID: 39717160
Background: Inferior vena cava agenesis (IVCA) is a rare vascular abnormality characterised by the absence of one or more segments of the inferior vena cava and represents an underestimated cause...
3.
Urru S, Mayer F, Spila Alegiani S, Paoloni F, Guella A, Murru R, et al.
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39410038
The clinical safety and efficacy of rituximab biosimilars compared to the reference rituximab (Mabthera) have been well established in randomized trials. However, concerns persist regarding the safety of changing from...
4.
Cai T, Boeri L, Miacola C, Palumbo F, Albo G, Ditonno P, et al.
Minerva Endocrinol (Torino)
. 2024 Sep;
50(1):84-96.
PMID: 39259514
Introduction: Male fertility relies on a complex physiology that may be negatively influenced by lifestyle, diet, and environment. The beneficial effect of nutraceuticals on male fertility is a debated claim....
5.
Miraki Feriz A, Khosrojerdi A, Erfanian N, Azarkar S, Sajjadi S, Shojaei M, et al.
Immunobiology
. 2024 Jun;
229(4):152822.
PMID: 38852289
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy that represents a significant challenge in cancer research and clinical management. In this study, we reanalyzed a published single-cell RNA sequencing...
6.
Speranza D, Santarpia M, Luppino F, Omero F, Maiorana E, Cavaleri M, et al.
Expert Opin Drug Saf
. 2024 May;
23(11):1405-1418.
PMID: 38819976
Introduction: Although immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, the consequential over activation of the immune system is often complicated by adverse events that can affect several organs and...
7.
Leone P, Malerba E, Prete M, Solimando A, Croci G, Ditonno P, et al.
Biomark Res
. 2024 Apr;
12(1):43.
PMID: 38654298
Background: Activation of CD28 on multiple myeloma (MM) plasma cells, by binding to CD80 and CD86 on dendritic cells, decreases proteasome subunit expression in the tumor cells and thereby helps...
8.
Casagrande S, Sopetto G, Bertalot G, Bortolotti R, Racanelli V, Caffo O, et al.
Cancers (Basel)
. 2024 Apr;
16(7).
PMID: 38611115
The landscape of cancer treatment has undergone a significant transformation with the introduction of Immune Checkpoint Inhibitors (ICIs). Patients undergoing these treatments often report prolonged clinical and radiological responses, albeit...
9.
Leone P, Malerba E, Susca N, Favoino E, Perosa F, Brunori G, et al.
Front Immunol
. 2024 Mar;
15:1367875.
PMID: 38426109
The tumor microenvironment is a highly complex and dynamic mixture of cell types, including tumor, immune and endothelial cells (ECs), soluble factors (cytokines, chemokines, and growth factors), blood vessels and...
10.
Prete M, Racanelli V, Leone P, Favoino E, Perosa F
Clin Case Rep
. 2024 Feb;
12(2):e8446.
PMID: 38389963
Pyoderma gangrenosum is a rare inflammatory ulcerative skin disease of unknown etiology. We report an image of a patient with pyoderma gangrenosum who presented right leg ulcers with violaceous margins,...